The angiogenesis mechanism alone should give anyone pause given the theoretical cancer-promotion risk Not to be a hammer looking at a nail but even if we remove questions about the safety and efficacy of peptides in purified forms which is itself an intolerably large assumption - what risks are peptide users facing from consuming research grade materials produced under non-GMP conditions procured from internet brokers
19 892
Is this the same as standalone tirzepatide
Extra caution is appropriate in patients with active cancer, recent cancer, unexplained masses, unexplained weight loss, pregnancy, breastfeeding, known allergy to peptide products, active infection, immune compromise, significant liver or kidney disease, active inflammatory or autoimmune disease flares, unusual clotting history, uncontrolled cardiovascular disease, use of chemotherapy or immune-modifying biologic therapy, and competitive athletes subject to anti-doping rules